Literature DB >> 7270857

[Pharmacokinetics of midazolam in man (author's transl)].

P M Lauven, H Stoeckel, H Ochs, D J Greenblatt.   

Abstract

Plasma concentrations of midazolam (Ro 21-3981/001) were studied in six gynaecological patients following a 12.5 mg intravenous bolus injection of the drug for induction of anaesthesia. The plasma decay curves were found to be biphasic. Therefore the data were interpreted according to an open two compartment model. The fast distribution phase (alpha-phase) lasted about 30 to 45 min with a mean halflife of about 8-9 min. The half-life of the slow redistribution and elimination phase (beta-phase) amounted to a mean of about 150 min. The apparent volume of distribution of the cental compartment (V1) was calculated as 24.11 and the volume of distribution at steady state as 84.21 (Vd, ss). The volume of distribution in the beta-phase (Vd beta) ranged from 71.5 to 129.51 with a mean of 104.21. The total plasma clearance varied from 380 to 527 ml/min with a mean of 472 ml/min. It is suggested that the pharmacokinetic behavior is due to water-solubility and plasma protein binding of this new benzodiazepine.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7270857

Source DB:  PubMed          Journal:  Anaesthesist        ISSN: 0003-2417            Impact factor:   1.041


  3 in total

1.  [Drugs for intravenous induction of anesthesia: ketamine, midazolam and synopsis of current hypnotics].

Authors:  E Halbeck; C Dumps; D Bolkenius
Journal:  Anaesthesist       Date:  2018-08       Impact factor: 1.041

Review 2.  [Benzodiazepines: significance of kinetics for therapy].

Authors:  H R Ochs
Journal:  Klin Wochenschr       Date:  1983-03-01

Review 3.  Midazolam. A review of its pharmacological properties and therapeutic use.

Authors:  J W Dundee; N J Halliday; K W Harper; R N Brogden
Journal:  Drugs       Date:  1984-12       Impact factor: 9.546

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.